Kirkland guides JP Morgan in $500M Biotech Venture Fund
TLDR: Kirkland advised J.P. Morgan Private Capital on the closing of its biotechnology venture capital fund, 270 Life Sciences Private Capital Fund I, which closed above its $500 million target. The fund